Dosing Mix-up Raises Questions About New COVID Vaccine
Video Credit: Wochit News - Duration: 00:39s - Published
Dosing Mix-up Raises Questions About New COVID Vaccine
A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed.
The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford.
Less than a week after we learned about it, the developers have admitted to a manufacturing error.
The error resulted from two different doses during the recently concluded phase III trial.
AstraZeneca and the University of Oxford described the vaccine as being 70% effective.
![COVID Vaccines That Require 2 Doses Create New Set Of Challenges [Video]](https://video.newsserve.net/300/v/20201130/2011302242-COVID-Vaccines-That-Require-Doses-Create-New.jpg)
![Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials [Video]](https://video.newsserve.net/300/v/20201130/2011302235-Moderna-Applies-For-Emergency-FDA-Authorization-After-Successful.jpg)
![Moderna to file for emergency authorization of its Covid-19 vaccine in US and Europe|Oneindia News [Video]](https://video.newsserve.net/300/v/20201130/1313843074-Moderna-to-file-for-emergency-authorization-of-its.jpg)
